News | September 12, 2025
Briefs: Torrent Pharmaceuticals and Hemant Surgical Industries
Hemant Surgical Industries receives order
Hemant Surgical Industries receives order
Program provides access to Lilly-trained artificial intelligence to help accelerate breakthrough medicines
Transformation to increase speed and redirect resources to growth opportunities within diabetes and obesity, aiming at reaching millions of untreated patients
The cGMP-4 facility will further strengthen the company's ability to serve global partners
Tourmaline Bio is a clinical-stage biopharmaceutical company developing pacibekitug, an anti-IL-6 mAb, as a treatment option for atherosclerotic cardiovascular disease
MKP11093 has shown strong results in preclinical studies with a promising safety and selectivity profile
Mansam, founded in 2022, is positioned as the first Arabian luxury fragrance brand with a vision for global expansion
New unit boosts innovation in liposomal delivery technologies with 8,500 MT capacity and export-ready production
Accelerating RNA-based therapeutic solutions for customers through co-development of products and formulation support
The facility has been designed with a dual focus on efficiency and sustainability
Subscribe To Our Newsletter & Stay Updated
